Dhurandhar Leads US Pre-Sales Over Yash's Toxic

The US box office is witnessing an early skirmish between Ranveer Singh's "Dhurandhar: The Revenge" and Yash's "Toxic." As of March 1, 2026, "Dhurandhar 2" has initiated its pre-sales, amassing a gross of $13,000 by selling approximately 768 tickets across 113 locations. This performance puts it ahead of Yash's "Toxic," which has registered $3.3K in pre-sales, selling 173 tickets from 71 locations.

With 18 days remaining until their premiere, "Dhurandhar: The Revenge" shows a significant lead in advance ticket sales. However, "Toxic" currently has fewer shows available, a factor that may change as pre-sales ramp up. The anticipation is high for both Indian blockbusters, which are scheduled for a worldwide theatrical release on March 19, 2026, promising a notable box office clash.